Company page

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. (VRDN) is a publicly traded company based in the United States, with a market capitalization of approximately $1.81 billion. The company focuses on developing innovative therapies for patients with serious diseases. As part of the biotechnology sector, Viridian is dedicated to advancing its research and product pipeline to address unmet medical needs.